ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,781, issued on Jan. 20, was assigned to Gasherbrum Bio Inc. (South San Francisco, Calif.).
"Heterocyclic GLP-1 agonists" was invented by Qinghua Meng (Shanghai), Hui Lei (Shanghai), Haizhen Zhang (Shanghai), Xichen Lin (Shanghai) and Andrew Jennings (South San Francisco, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to GLP-1 agonists of Formula I:including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same."
The patent was filed on Dec. 8, 2023, under Application No. 18/534,517.
*For further information, including images, charts and tables, please visit: http:/...